Natia Peradze M.D.

Natia Peradze MD PhD is a seasoned medical professional with extensive experience in clinical development and research. Currently serving as Director of Early Clinical Development for Cardiovascular, Renal, and Metabolism at AstraZeneca since November 2024, Natia's previous roles include Study Director/Senior Scientist at Invicro and Post-Doctoral Research Fellow at Beth Israel Deaconess Medical Center. With a background that encompasses research scientist positions at both Va Health Care Systems and Universitätsklinikum Freiburg, along with attending physician roles at the Institute of Clinical Oncology and O. Gudushaurl National Medical Centre, Natia has cultivated a robust expertise in endocrinology, diabetes, and metabolism. Educational qualifications include a Post Doctoral Fellowship from Harvard Medical School, a PhD in Endocrinology, Diabetes, and Metabolism from The University of Freiburg, and an MD from Tbilisi State Medical University.